Related references
Note: Only part of the references are listed.Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
Frederick M. Lang et al.
NEURO-ONCOLOGY (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas
Brittany C. Parker Kerrigan et al.
CYTOTHERAPY (2017)
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions
Janice Kim et al.
VIRUSES-BASEL (2015)
Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas
Kaisorn L. Chaichana et al.
THERAPEUTIC DELIVERY (2015)
Mesenchymal stem cells: immune evasive, not immune privileged
James A. Ankrum et al.
NATURE BIOTECHNOLOGY (2014)
Glioma virus therapies between bench and bedside
Johanna K. Kaufmann et al.
NEURO-ONCOLOGY (2014)
TGF-β Mediates Homing of Bone Marrow-Derived Human Mesenchymal Stem Cells to Glioma Stem Cells
Naoki Shinojima et al.
CANCER RESEARCH (2013)
Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
Matthew D. Griffin et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Oncolytic Virus Therapy for Glioblastoma Multiforme Concepts and Candidates
Guido Wollmann et al.
CANCER JOURNAL (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Mesenchymal Stem Cells: A New Promise in Anticancer Therapy
Sabino Ciavarella et al.
STEM CELLS AND DEVELOPMENT (2011)
Directing systemic oncolytic viral delivery to tumors via carrier cells
Hiroshi Nakashima et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Platelet-Derived Growth Factor BB Mediates the Tropism of Human Mesenchymal Stem Cells for Malignant Gliomas
Nobuhiro Hata et al.
NEUROSURGERY (2010)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas
Hong Jiang et al.
CURRENT GENE THERAPY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: Correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect
O Szentirmai et al.
NEUROSURGERY (2006)
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells
SN Robinson et al.
BONE MARROW TRANSPLANTATION (2006)
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
A Nakamizo et al.
CANCER RESEARCH (2005)
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
K Le Blanc et al.
EXPERIMENTAL HEMATOLOGY (2003)
An implantable guide-screw system for brain tumor studies in small animals
S Lal et al.
JOURNAL OF NEUROSURGERY (2000)